Physician profile
Pratip Patel
NPI 1891801692
$898.95
in general payments reported to CMS, 2019-2025
15 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.31 · 2020: $16.79 · 2021: $181 · 2022: $156 · 2023: $226 · 2024: $174 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.36 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $118.16 | 2022-2023 | Eliquis |
| Pfizer INC. | $89.22 | 2019-2024 | |
| Glaxosmithkline, LLC. | $68.80 | 2021-2025 | Trelegy Ellipta |
| Abbvie INC. | $50.23 | 2021 | |
| Abbott Laboratories | $41.47 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $32.05 | 2024 | Mounjaro, Jardiance |
| Amgen INC. | $27.99 | 2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $26.77 | 2022-2024 | Airsupra |
| Dexcom, INC. | $22.24 | 2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $19.31 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.43 | 2021 | |
| Genentech USA, INC. | $14.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.08 | 2019 | |
| Nevro Corp. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratip Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.